- Home
- ACHV vs BZUN Comparison
ACHV vs BZUN Comparison
Compare ACHV & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- BZUN
- Stock Information
- Founded
- ACHV N/A
- BZUN 2007
- Country
- ACHV United States
- BZUN China
- Employees
- ACHV N/A
- BZUN N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BZUN Catalog/Specialty Distribution
- Sector
- ACHV Health Care
- BZUN Consumer Discretionary
- Exchange
- ACHV Nasdaq
- BZUN Nasdaq
- Market Cap
- ACHV 131.2M
- BZUN 144.4M
- IPO Year
- ACHV N/A
- BZUN N/A
- Fundamental
- Price
- ACHV $2.55
- BZUN $2.77
- Analyst Decision
- ACHV Strong Buy
- BZUN Buy
- Analyst Count
- ACHV 3
- BZUN 2
- Target Price
- ACHV $14.33
- BZUN $3.20
- AVG Volume (30 Days)
- ACHV 652.7K
- BZUN 228.2K
- Earning Date
- ACHV 08-07-2025
- BZUN 08-28-2025
- Dividend Yield
- ACHV N/A
- BZUN N/A
- EPS Growth
- ACHV N/A
- BZUN N/A
- EPS
- ACHV N/A
- BZUN N/A
- Revenue
- ACHV N/A
- BZUN $1,310,110,798.00
- Revenue This Year
- ACHV N/A
- BZUN $5.27
- Revenue Next Year
- ACHV N/A
- BZUN $3.46
- P/E Ratio
- ACHV N/A
- BZUN N/A
- Revenue Growth
- ACHV N/A
- BZUN 6.77
- 52 Week Low
- ACHV $1.84
- BZUN $2.12
- 52 Week High
- ACHV $5.31
- BZUN $4.38
- Technical
- Relative Strength Index (RSI)
- ACHV 46.32
- BZUN 51.59
- Support Level
- ACHV $2.37
- BZUN $2.73
- Resistance Level
- ACHV $2.56
- BZUN $2.77
- Average True Range (ATR)
- ACHV 0.12
- BZUN 0.11
- MACD
- ACHV 0.01
- BZUN 0.00
- Stochastic Oscillator
- ACHV 47.37
- BZUN 41.30
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.